Celularity Inc (CELU)
3.37
-0.09
(-2.60%)
USD |
NASDAQ |
May 28, 16:00
3.37
0.00 (0.00%)
After-Hours: 18:36
Celularity Total Assets (Quarterly): 157.19M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 157.19M |
| June 30, 2023 | 246.42M |
| March 31, 2023 | 362.42M |
| December 31, 2022 | 401.07M |
| September 30, 2022 | 437.12M |
| June 30, 2022 | 429.34M |
| Date | Value |
|---|---|
| March 31, 2022 | 434.20M |
| December 31, 2021 | 414.13M |
| September 30, 2021 | 448.29M |
| June 30, 2021 | 128.42M |
| December 31, 2020 | 431.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
128.42M
Minimum
Jun 2021
448.29M
Maximum
Sep 2021
353.60M
Average
414.13M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 126.94M |
| Shareholders Equity (Quarterly) | 30.25M |
| Debt to Equity Ratio | 1.157 |
| Current Ratio | 0.1949 |
| Net Debt Paydown Yield | -16.28% |